This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gaziev D, Galimberti M, Polchi P . Treatment of chronic graft-versus-host disease: is there an alternative to conventional treatment? Bone Marrow Transplant 2000 25: 689–696
Sullivan K, Witherspoon R, Storb R et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation Blood 1988 72: 546–554
Gilman AL, Beams F, Tefft M, Mazumder A . Effects of hydroxychloroquine on alloreactivity and its potential use for graft-vs-host disease Bone Marrow Transplant 1996 17: 1069–1075
Schultz KR, Bader S, Paquet J, Wei L . Chloroquine treatment affects T cell priming to minor histocompatibility antigens and graft-vs-host disease Blood 1995 86: 4344–4352
Schultz KR, Bader S, Nelson D et al. Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist? Transplantation 1997 64: 1055–1065
Schultz KR, Nelson O, Bader S . Synergy between lysosomotropic amines and cyclosporin A on human T cell responses to an exogenous antigen, tetanus toxoid Bone Marrow Transplant 1996 18: 625–631
Schultz KR, Gilman AL . The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease Leuk Lymphoma 1997 24: 201–210
Goldman FD, Gilman AL, Hollenback C et al. Hydroxychloroquine inhibits calcium signals in T cells, a new mechanism to explain its immunomodulatory properties Blood 2000 95: 3467–3472
Gilman AL, Morris C, Mogul M et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease American Society of Hematology, thirty-eighth Annual Meeting December 1996
Gilman A, Chan KW, Mogul M et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease American Society for Blood and Marrow Transplantation Meeting March 1999
Gilman AL, Chan KW, Mogul M et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease Biol Blood Marrow Transplant (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilman, A., Schultz, K. Treatment of chronic GVHD. Bone Marrow Transplant 26, 460–461 (2000). https://doi.org/10.1038/sj.bmt.1702530
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702530